US20090011108A1 - Hydrated Food - Google Patents

Hydrated Food Download PDF

Info

Publication number
US20090011108A1
US20090011108A1 US11/911,249 US91124906A US2009011108A1 US 20090011108 A1 US20090011108 A1 US 20090011108A1 US 91124906 A US91124906 A US 91124906A US 2009011108 A1 US2009011108 A1 US 2009011108A1
Authority
US
United States
Prior art keywords
theanine
acid
pyroglutamic acid
solution
taste
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/911,249
Other languages
English (en)
Inventor
Shizuka Kogiso
Makoto Ozeki
Nobuyuki Aoi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAIYOKAGAKU CO Ltd
Original Assignee
TAIYOKAGAKU CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAIYOKAGAKU CO Ltd filed Critical TAIYOKAGAKU CO Ltd
Assigned to TAIYOKAGAKU CO., LTD. reassignment TAIYOKAGAKU CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AOI, NOBUYUKI, KOGISO, SHIZUKA, OZEKI, MAKOTO
Publication of US20090011108A1 publication Critical patent/US20090011108A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/60—Sweeteners
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to a hydrated food containing as active ingredient pyroglutamic acid and theanine. Furthermore, the invention relates to a hydrated food which can stably maintain a content of theanine during preservation and improve a taste threshold by the presence of pyroglutamic acid in a solution of theanine, glutamine or glutamic acid. Still furthermore, the hydrated food can improve taste peculiar to branched chain amino acids, synthetic sweeteners and peptides.
  • Theanine used in the present invention has effects of mood disorder curing, mind concentration improving, difficult menstruation suppression, flavor improvement composition and sleep facilitation, and thus, it is known that theanine has beneficial physiological effects.
  • 20 cups of tea need to be taken per occasion as an intake for adult. Accordingly, it is substantially impossible to take theanine from only tea.
  • Development of a hydrated food containing theanine has been desired for the purpose of easily taking theanine.
  • theanine is preserved in a water-soluble liquid composition, theanine is decomposed with progress of time, whereupon there is a problem that a content of theanine is reduced when a hydrated food containing theanine is preserved for a long period of time.
  • theanine when melted into a high concentrated state, theanine has its peculiar taste though theanine is a highly seasoned amino acid. Every taste has a threshold, which is the minimum concentration at which taste sensitivity to a particular substance or food can be perceived.
  • Theanine has a threshold of 150 mg/100 ml
  • glutamine has a threshold of 250 mg/100 ml
  • glutamic acid has a threshold of 5 mg/100 ml.
  • Valine has a threshold of 150 mg/100 ml
  • leucine has a threshold of 380 mg/100 ml
  • isoleucine has a threshold of 90 mg/100 ml.
  • Taste is perceived when the concentration is equal to or higher than the threshold. The taste sometimes affects the hydrated food.
  • acesulfame K, aspartame and L-phenylalanine all of which are synthetic sweeteners have respective unique bitterness. Some peptides also have bitterness at about 1000 mg/100 ml.
  • patent document 1 discloses a technique for utilizing pyroglutamic acid as food. As disclosed, when pyroglutamic acid is contained in a frozen food, a period of time necessary for freezing and thawing the food is shortened and freezing denaturation of food can be suppressed. However, few things are generally known about the effects of pyroglutamic acids.
  • An object of the present invention is to provide a hydrated food which contains pyroglutamic acid and theanine and in which a stable content of theanine can be maintained even when the hydrated food is preserved for a long period of time and which can increase the threshold of food and flavor the peculiar taste.
  • the inventors made repeated investigations in view of the above objects and found that the content of theanine in a hydrated food was stabilized by the use of pyroglutamic acid in the hydrated food containing theanine.
  • pH of the hydrated food ranges from about 2.8 to about 7.5
  • stable content of theanine can be maintained even though the hydrated food is a beverage or gel-food.
  • the inventors found that the taste peculiar to theanine was reduced even in a solution in which theanine more than a threshold of amino acid is dissolved and food having bitterness could be flavored, thereby basically made the invention.
  • the present invention is each of the following (1) to (5):
  • a hydrated food characterized by containing (A) pyroglutamic acid;
  • a hydrated food characterized by containing one or more amino acids selected from groups comprising (A) pyroglutamic acid, (B) theanine, glutamine and glutamic acid;
  • a hydrated food characterized by containing one or more amino acids selected from groups comprising (A) pyroglutamic acid, (B) theanine, glutamine and glutamic acid, and (C) branched chain amino acid;
  • a hydrated food characterized by containing one or more amino acids selected from groups comprising (A) pyroglutamic acid, (B) theanine, glutamine and glutamic acid, and one or more synthetic sweeteners selected from a group of (D) acesulfame K, aspartame and L-phenylalanine;
  • a hydrated food characterized by containing one or more amino acids selected from groups comprising (A) pyroglutamic acid, (B) theanine, glutamine and glutamic acid, and (E) peptide;
  • a pyroglutamic acid used in the present invention is also known as pyrrolidone carboxylic acid (2-pyrrolidone-5-carboxylic acid) and is a derivative of amino acid having a molecular formula of C 5 H 7 NO 3 and a molecular weight of 129.
  • the substance is present in sufficient quantity in Steffen's Waste which is a byproduct in the manufacture of sugar beet.
  • L-glutamic acid is hydrolyzed at 175° C., partially racemized pyroglutamic acid is obtained.
  • L-glutamic acid- ⁇ -methyl ester or L-glutamic acid- ⁇ -ethyl ester is left in methanol saturated with ammonia, optically pure pyroglutamic acid can readily be obtained.
  • the obtained pyroglutamic acid has a rhombic column crystal and a melting point ranging from 159° C. to 160.5° C., and is an easily water-soluble substance.
  • the pyroglutamic acid used in the present invention can be used as salt.
  • the salt should not be limited to a specific one and monovalent, bivalent or trivalent salt can be used. In particular, it is preferable to use monovalent salt (preferably, potassium chloride or sodium chloride).
  • a pyroglutamic acid obtained by any method is available as the pyroglutamic acid used in the present invention.
  • the pyroglutamic acid may be extracted from a plant such as sugar beet or isolated from a hot-water extract of various animals or may be a derivative from glutamic acids, glutamine or the like.
  • the pyroglutamic acid used in the present invention has a content ranging from about 0.0003% to about 40% relative to total mass of the hydrated food.
  • Theanine used in the present invention is known as a principal component of deliciousness of green tea and is an important substance as a flavor component of food such as tea.
  • Methods of making theanine used in the invention include a method of extracting theanine form tea leaves, a method of obtaining theanine by organic synthesis reaction (Chem. Pharm. Bull.
  • Green tea, oolong tea, tea and the like are exemplified as the leaves of tea. Any one of L-, D- and DL-theanine may be used. L-theanine is preferable in the invention since it is particularly recognized as food additives and is economic in use.
  • theanine used in the invention may be any one of a refined product containing 98% or more of theanine, rough refined product with content of theanine ranging from 50% to 98% and extract with content of theanine ranging from 10% to 50%.
  • Theanine used in the invention has a high security. For example, in an acute toxicity test with use of mice, no mice died and abnormality was found in an ordinary state, weight and the like even in the case of oral administration of theanine by 5 g/kg. Furthermore, theanine is known as a principal component of deliciousness of tea and used as a food additive for use as gustatory. An amount of theanine to be added is not limited under the Food Sanitation Law.
  • Glutamine in the present invention is a 2-aminoglutalamid acid and becomes glutamic acid by acid hydrolysis. Glutamine is classified into polar non-charged side-chain amino acids or neutral polar side-chain amino acids. Glutamine is one of amino acids composing protein which is contained in a large amount in extracellular fluid of animals and is a non-essential amino acid. However, since a rise of catabolism such as metabolic stress sometimes renders an amount of glutamic biosynthesis in the body short, glutamine is treated as quasi-essential amino acid. Glutamine in the invention is synthesized from glutamic acid by the action of glutamine synthetase (glutamic acid ammonia ligase, EC 6.3.1.2). However, glutamine may be manufactured by another manufacturing method.
  • Glutamine in the present invention is a 2-aminoglutalamid acid and was first found from hydrolysate of wheat gluten.
  • Monosodium glutamate (MSG) which is sodium salt of glutamic acid is used as a chemical seasoning.
  • Glutamic acid is classified into acidic polar side-chain amino acids.
  • Glutamic acid is one of amino acids composing protein and a non-essential amino acid.
  • Glutamic acid also functions as a neurotransmitter in animal bodies.
  • a sea tangle, cheese, green tea and the like are known to contain a large amount of glutamic acid.
  • a mushroom, tomato, sea food and the like are also known to contain a large amount of glutamic acid.
  • Glutamic acid in the invention is synthesized by causing 2-oxoglutaric acid in a citric acid cycle to receive an amino group from another amino acid by the action of glutamic transferase or by reverse reaction of degradation of glutamic acid into 2-oxoglutaric acid and ammonia by glutamate dehydrogenase (EC 1.4.1.3).
  • Glutamic acid is primarily used for manufacture as an intermediate material of monosodium glutamate which is a food additive. Since glutamic acid itself has acidity, neutralized sodium salt is used as a seasoning.
  • Glutamic acid in the invention may be obtained by any one of methods of producing by amino-acid fermentation of microbe with molasses or rice, cornstarch and ammonium chloride serving as materials; obtaining by adding hydrochloric acid to vegetable albumin such as soybean albumin or gluten and hydrolyzing the addition in a high temperature atmosphere; extracting, by the Steffen process, waste molasses produced in the process of making beet sugar from beet; separating L-glutamic acid from DL-glutamic acid obtained by carboxylation, cynoamin, or hydration of acrylonitrile as a material; and amino-acid fermentation of microbe by the action of coenzyme and enzyme such as glutamate dehydrogenase, amino transferase or the like with molasses or rice, cornstarch and ammonium chloride serving as materials.
  • coenzyme and enzyme such as glutamate dehydrogenase, amino transferase or the like with molasses or rice, cornstarch and
  • Branched amino acid in the invention is Valine, leucine or isoleucine.
  • the branched amino acid has a structure that a chain of carbon (methyl group: —CH 3 ) is branched.
  • These three amino acids are named generically “branched chain amino acid” (BCAA).
  • BCAA branched chain amino acid
  • the branched chain amino acid is an essential amino acid and occupies about 50% of essential amino acids contained in food protein and about 35% of essential amino acids contained in protein of muscle.
  • the branched chain amino acid performs an important role as a material for muscles (protein) of a human body and as an energy source during physical activities.
  • the branched chain amino acid is metabolized in muscles.
  • glucide Upon a hard physical activity, glucide is first used as an energy source. When the glucide has been consumed, protein in muscles is decomposed into branched chain amino acids, which are used as an energy source.
  • the branched chain amino acid is easy to be converted to energy. It is known that the branched chain amino acid suppresses reduction in muscles and muscle weakness, makes up for stamina and increases endurance. Furthermore, it is known that the branched chain amino acid has effects of smoothly reproducing muscles and suppressing a value of blood lactic acid as a fatigue-producing substance to prevent muscular fatigue and suppressing increase in serotonin as neurotransmitter in the brain to prevent tired feeling and reduction in vigor and powers of concentration. Valine of the branched chain amino acid is known to have functions of adjustment of nitrogen balance, promotion of growth and adjustment of nervous system as well as metabolic promotion and a function as energy source.
  • Leucine promotes synthesis of skin, bone and muscle and suppresses degradation of muscular organization and accordingly has effects of recovering from fatigue, increasing the physical strength, improving liver functions and adjusting blood glucose level.
  • Isoleucine is known to have effects of promoting growth, adjusting functions of nerve system, expanding blood vessels and improving liver functions.
  • Acesulfame K (acesulfame potassium) is an artificial sweetener made from a material of “diketene” which is also used as dyes and pigments and synthetic material of pharmaceuticals. Acesulfame K is 200 times sweeter than sugar and has a high heat resistance and is stable. Acesulfame K received approval as a food additive in 2000 in Japan.
  • Aspartame in the invention is an ester of aspartic acid, phenylalanine and methanol and is about 200 times sweeter than sugar.
  • L-phenylalanine in the invention is a glycogenic essential amino acid and is known to become a synthetic material for a neurotransmitter of noradrenaline and dopamine in the brain. These synthetic sweeteners have peculiar bitterness as an aftertaste.
  • Peptide in the invention is a polymer of two or more amino acids and is obtained by synthesis or degradation of protein.
  • the peptide is natural or synthetic and contains hydrolysate of protein and fraction thereof.
  • the peptide is a simple or a mixture of them or a mixture of amino acid and peptide.
  • the hydrated food of the invention is exemplified a preferred beverage, refreshing beverage, carbonated beverage, fruit beverage, lactic acid drink, lactic beverage, sports drink, diet drink, supplementary beverage, alcohol-containing beverage, liquid beverage or solid jerry both made by blending gelatinizing agent and the like.
  • the hydrated food of the invention should not be limited particularly, designates all the beverages containing water.
  • a water content should not be limited and is normally not less than 50%, preferably not less than 80%, more preferably not less than 90%, and most preferably not less than 90%.
  • the hydrated food of the invention has pH ranging from about 2.8 to about 7.5, preferably ranging from about 4.3 to about 7.0, further preferably ranging from about 5.0 to about 6.0.
  • the pH is adjusted in the range so that a content of theanine in the hydrated food is easy to be maintained stably for a long period of time.
  • a pH adjusting agent should not be limited.
  • a food additive such as a citric acid, malic acid, tartaric acid, phosphoric acid, maleic acid, ascorbic acid or acetic acid and a natural substance such as lemon.
  • the hydrated food of the invention contains theanine whose concentration ranges from about 0.03 mg/mL to about 250 mg/mL, preferably ranges from about 0.3 mg/mL to about 250 mg/mL, more preferably ranges from about 1.5 mg/mL to about 250 mg/mL. When the concentration exceeds 250 mg/mL, the theanine cannot be dissolved since the value is an upper limit of dissolution.
  • Pyroglutamic acid and theanine both contained in the hydrated food of the invention have a mass ratio (that is, pyroglutamic acid/theanine) ranging from about 0.1% to about 200%, preferably ranges from about 0.5% to about 100%, more preferably ranges from about 5% to about 50%.
  • pyroglutamic acid/theanine a mass ratio ranging from about 0.1% to about 200%, preferably ranges from about 0.5% to about 100%, more preferably ranges from about 5% to about 50%.
  • pyroglutamic acid and glutamine have a mass ratio (that is, pyroglutamic acid/glutamine) ranging from about 0.05% to about 100%, preferably ranges from about 0.1% to about 50%, more preferably ranges from about 1% to about 30%.
  • a taste peculiar to glutamine is easy to reduce.
  • glutamic acid may be flavored in the hydrated food of the invention
  • pyroglutamic acid and glutamic acid have a mass ratio (that is, pyroglutamic acid/glutamic acid) ranging from about 3% to about 6000%, preferably ranges from about 15% to about 3000%, more preferably ranges from about 150% to about 1500%.
  • a taste peculiar to glutamine is easy to reduce.
  • valine acid may be flavored in the hydrated food of the invention
  • pyroglutamic acid and valine have a mass ratio (that is, pyroglutamic acid/valine) ranging from about 0.1% to about 200%, preferably ranges from about 0.5% to about 100%, more preferably ranges from about 5% to about 50%.
  • a bitter taste peculiar to valine is easy to reduce.
  • glutamic acid may be flavored in the hydrated food of the invention
  • pyroglutamic acid and leucine have a mass ratio (that is, pyroglutamic acid/leucine) ranging from about 0.03% to about 80%, preferably ranges from about 0.2% to about 40%, more preferably ranges from about 2% to about 20%.
  • a bitter taste peculiar to glutamine is easy to reduce.
  • pyroglutamic acid and isoleucine have a mass ratio (that is, pyroglutamic acid/isoleucine) ranging from about 0.1% to about 300%, preferably ranges from about 1% to about 200%, more preferably ranges from about 10% to about 100%.
  • a bitter taste peculiar to valine is easy to reduce.
  • pyroglutamic acid and acesulfame K have a mass ratio (that is, pyroglutamic acid/acesulfame K) ranging from about 100% to about 10000%, preferably ranges from about 50% to about 5000%, more preferably ranges from about 10% to about 1000%.
  • a mass ratio that is, pyroglutamic acid/acesulfame K
  • pyroglutamic acid and aspartame have a mass ratio (that is, pyroglutamic acid/aspartame) ranging from about 100% to about 10000%, preferably ranges from about 50% to about 5000%, more preferably ranges from about 10% to about 1000%.
  • pyroglutamic acid/aspartame a mass ratio ranging from about 100% to about 10000%, preferably ranges from about 50% to about 5000%, more preferably ranges from about 10% to about 1000%.
  • L-phenylalanine may be flavored in the hydrated food of the invention
  • pyroglutamic acid and L-phenylalanine have a mass ratio (that is, pyroglutamic acid/L-phenylalanine) ranging from about 10% to about 1000%, preferably ranges from about 5% to about 500%, more preferably ranges from about 1% to about 100%.
  • a bitter taste peculiar to L-phenylalanine is easy to reduce.
  • pyroglutamic acid and peptide have a mass ratio (that is, pyroglutamic acid/peptide) ranging from about 1% to about 800%, preferably ranges from about 5% to about 400%, more preferably ranges from about 10% to about 200%.
  • a bitter taste peculiar to L-phenylalanine is easy to reduce.
  • the hydrated food of the invention may contain simple sugar used in ordinary foods or the like, nonreducing sugar, natural sweetener, artificial sweetener, polysaccharide, food fiber and gelling agent.
  • pentose such as glucose, fructose, galactose, mannose, ribose, deoxyribose and the like
  • hexose such as glucose, fructose, galactose and the like
  • the hydrated food of the invention may generally contain flavoring substances used in a food or the like.
  • flavoring substances are exemplified various types of flavors, for example, lemon flavor, orange flavor, grapefruit flavor, chocolate flavor, dl-menthol, l-menthol or the like.
  • the hydrated food of the invention may be used with natural medicines, herbs, amino acids, peptide, vitamins, minerals, other foods, materials allowed as pharmaceutical products.
  • natural medicines may include valenian, angelicae radix, paeoniae radix, tree peony, ginseng, etc.
  • the amino acid may include glycine, alanine, praline, hydroxyproline, histidine, arginine, lysine, hydroxylysine, tyrosine, triptophan, asparagines, asparagine acid, glutamine, glutamic acid, hydroxyproline, serine, threonine, methionine, cysteine, natural or synthetic cystine
  • the herb may include anise, carrot seed, cloves, coriander, cypress, cinnamon, juniper, ginger, sweet orange, basil, patchouli, bitter orange, fennel, black pepper, bay, peppermint, bergamot, mandarin, myrrh, lemon grass, rosemary, vanilla, hyssop, eucalyptus , lime, lemon, ylangylang, cardamom, clarysage, jasmine, geranium , Bulgarian rose, rose, olibanum, matricaria , sandalwood, verbena , petit grain, vetivera zizanoides , marjoram, Melissa officinelis , rosewood, Hypericum , St. Jones Wart and kava kava.
  • the vitamin may include vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, niacin, lipoic acid, pantothenic acid, biotin and ubiquinone.
  • Vitamin B1, B6 and B12 are more preferable.
  • the vitamins include the derivatives thereof.
  • the mineral may include calcium, iron, magnesium, copper, zinc, selenium and potassium.
  • the following material may be used with the tablet of the invention: aloe, royal jelly, placenta, propolis, isoflavone, soy isoflavone, egg yolk lecithin, lecithin, chondroithin, cacao mass, collagen, vinegar, chlorella , spirulina, ginkgo leaf, green tea, hardy rubber tree, oolong tea, mulberry leaf, Rubus suavissimus, Lagerstroemia speciosa , unsaturated fatty acid, saccharide such as sugar alcohol and oligosaccharide, fungi such as bifidus bacillus, mushrooms such as agaricus, agaricus blazei Murrill, blacket fungus of the genus Fores, Grifola frondose , fruit such as blueberry, prune, grape, olive and plum, molokheiya such as peanut, almonde, sesame and pepper, vegetables such as green pepper, cayenne pepper, welsh onion,
  • the hydrated food of the invention may include oral foods such as beverages, jelly or the like manufactured by dispensing artificial colorant, preservative, antioxidant, thickening/stabilization agent, emulsifier, gelling agent or the like usually used in food manufacture, if necessary.
  • the hydrated food of the invention may include necessary foodstuff such as lipid, electrolyte or the like other than aforesaid acidifiers, sweeteners, amino acids, fragrant materials, herbs, vitamins and mineral.
  • the dehydrated food can be provided which is superior in a long period preservation and stability of theanine and can improve a taste threshold of food and flavor the food with respect to peculiar taste.
  • 0.3 M glutamine and 1.5 M methylamine hydrochloride were reacted in the presence of 0.3 U glutaminase (commercially available) at 30° C. for 22 hours in a buffer solution of 0.05 M boric acid (pH 11), whereby 225 nm theanine was obtained.
  • Reaction liquid was applied to Dowex 50 ⁇ 8 columnar chromatography and Dowex 1 ⁇ 2 columnar chromatography (both made by Muromachi Chemical Co., Ltd.) thereby to be processed by ethanol, whereby an object substance is isolated from the reaction liquid.
  • the isolated substance was applied to an amino acid analyzer (made by Hitachi Co.) and paper chromatography. Since the isolated substance behaved in the same way as a standard substance, it was recognized as L-theanine.
  • glutamine acid and ethylamine were produced in a ratio of 1:1.
  • glutaminase since the isolated substance was hydrolyzed by glutaminase, it was shown that ethylamine was ⁇ -ethylamine of glutamine acid.
  • glutamate dehydrogenase glutamine acid produced by hydrolysis was L-glutamine acid. As a result, 8.5 g theanine was obtained.
  • L-theanine product name: Suntheane made by Taiyo Kagaku Co., Ltd.
  • valine manufactured by Ajinomoto Co. Inc.
  • 10 mM citric sodium solution and 10 mM citric acid solution were suitably mixed together to be prepared so that pH of the mixture became 5.5, whereby a citric buffer fluid was prepared.
  • 200 mg of L-theanine was added to 100 mL of the buffer fluid to be dissolved and thereafter passed through a 0.45 ⁇ m filter, whereby 2 mg/mL L-theanine solution with pH of 5.5 was prepared.
  • 10 mM citric sodium solution and 10 mM citric acid solution were suitably mixed together to be prepared so that pH of the mixture became 4.3, whereby a citric buffer fluid was prepared.
  • 10 mg, 50 mg, 100 mg, 200 mg, 400 mg and 600 mg of L-theanine was each added to 100 mL of the buffer fluid to be dissolved and thereafter passed through a 0.45 ⁇ m filter, whereby 0.1 mg/mL, 0.5 mg/mL, 1 mg/mL, 2 mg/mL and 4 mg/mL and 6 mg/mL L-theanine solution with pH of 4.3 was prepared.
  • pyroglutamic acid was added to the theanine solution of embodiment 4 with pH of 2.8 relative to theanine and dissolved and agitated, and thereafter passed through a 0.45 ⁇ m filter, whereby pyroglutamic-acid containing theanine solution with pH of 2.8 was prepared.
  • the pyroglutamic acid was made by AJINOMOTO CO., INC.
  • pyroglutamic acid was added to the theanine solution of embodiment 4 with pH of 7.5 relative to theanine and dissolved and agitated, and thereafter passed through a 0.45 ⁇ m filter, whereby pyroglutamic-acid containing theanine solution with pH of 7.5 was prepared.
  • Theanine content in theanine solution prepared in each embodiment was determined using a high performance liquid chromatography (HPLC). Conditions of quantitative determination of HPLC are shown by the following table.
  • a pyroglutamic-acid added beverage was prepared using components as shown in the following TABLE 2. More specifically, to 8 L purified water were agitated and dissolved L-theanine, guagum degradation product (trade name: “Sunfiber HG” made by TAIYO KAGAKU CO., LTD.), pyroglutamic acid, DL-malic acid, granulated sugar, low-fructose corn syrup and 1 ⁇ 5 concentrated apple juice while being sequentially added to. Fragrance, citric sodium and purified water were added to the solution so that pH became 4.5. A total quantity of solution was set to 10 L and thereafter passed through a 0.22 ⁇ m sterilization filter. The solution was put into bistered bottles each having a content of 100 mL. A beverage containing 400 mg L-theanine per bottle was produced. Furthermore, a beverage containing no pyroglutamic acid was also produced.
  • a jelly beverage added with pyroglutamic-acid was prepared using composition as shown in the following TABLE 3. More specifically, with purified water were mixed a gelling agent (trade name: “Neosoft DAR” made by TAIYO KAGAKU CO., LTD.), L-theanine, pyroglutamic acid, granulated sugar and maltose water candy. The mixture was heated at 85° C. and dissolved and thereafter, mango puree, 1 ⁇ 5 concentrated lemon juice, fragrance and citric sodium were added to the mixture and prepared to pH of 4.5. The prepared mixture was processed by one-minute plate sterilization at 94° C., filtrated by the use of a 100-mesh filter and thereafter put into flexible pouches, whereby the jelly beverage was prepared. Furthermore, another jelly beverage added with no pyroglutamic acid was made as a comparative example.
  • a gelling agent trade name: “Neosoft DAR” made by TAIYO KAGAKU CO., LTD.
  • mango puree 1 ⁇ 5 concentrated
  • Theanine solution of each of embodiments 3 to 10 was put into a transparent and colorless vial every 20 mL and preserved in an incubator at 55° C. for six weeks.
  • beverage of embodiment 12 and jelly beverage of embodiment 13 were also preserved in the incubator at 55° C. for six weeks.
  • FIG. 1 shows theanine content in the solution of each embodiment after end of the preservation test.
  • the concentration of theanine solution of embodiment 3 was reduced to about 40% of an initially loaded quantity (2 mg/mL) and accordingly lacked for stability.
  • the concentration of theanine solution of embodiment 4 after the end of preservation test was reduced to about 74% of the initially loaded quantity.
  • the concentration of theanine solution of embodiment 5 was reduced to about 80%.
  • the concentration of theanine solution of embodiment 6 was reduced to about 90%.
  • each embodiment was improved in the stability of theanine.
  • the solution of embodiment 7 was reduced to about 76% of the initially loaded quantity and was more stable as compared with the solution of embodiment 3.
  • FIG. 2 shows theanine content after end of the preservation test.
  • the axis of abscissas in the figure designates theanine concentration. No changes in the stability with changes in the theanine concentration were recognized as shown in the figure.
  • FIG. 3 shows theanine content after end of the preservation test.
  • the axis of abscissas in the figure designates concentration of pyroglutamic acid relative to theanine content.
  • a residual ratio of theanine was about 75%.
  • the stability of theanine was slightly improved (77%).
  • the residual ratio of theanine was improved with increase in an amount of added pyroglutamic acid relative to theanine content.
  • the ratio of pyroglutamic acid/theanine was not less than 50%, the residual ratio of theanine was not less than 86%, whereupon remarkable stabilizing action was recognized.
  • FIG. 4 shows theanine content after end of the preservation test.
  • the axis of abscissas in the figure designates concentration of pyroglutamic acid relative to theanine content. When no pyroglutamic acid was contained (no addition), a residual ratio of theanine was about 92%.
  • Samples of the beverage of embodiment 12 were preserved in the manner of preservation test of test example 1 and evaluated by the theanine measurement method described in embodiment 11.
  • TABLE 4 shows theanine content after end of the preservation test.
  • 321 mg/100 mL (about 80%) of theanine remained when an initial amount of added theanine was 400 mg/100 mL.
  • 356 mg/100 mL (about 90%) of theanine remained in embodiment 12 of addition of pyroglutamic acid.
  • Ten panelists were invited to investigate whether the panelists felt the taste of glutamic acid when pyroglutamic acid was added to a glutamine solution.
  • the glutamic acid was made by AJINOMOTO CO., INC. TABLE 8 shows the number of panelists who felt the taste of glutamic acid at respective concentrations of glutamic acid and pyroglutamic acid.
  • the acesulfame K was made by TAKEDA-KIRIN FOODS CORPORATION.
  • the hydrated food can be provided in which theanine content can stably be maintained even when the hydrated food is preserved for a long period of time. Furthermore, the hydrated food can be provided in which the taste threshold of the food can be improved and the peculiar taste can be flavored.
  • a hydrated food characterized in that the theanine content ranges from about 0.03 mg/mL to about 200 mg/mL, and the pyroglutamine content ranges from about 1% to about 200% relative to the theanine content;
  • a hydrated food characterized in that the theanine content ranges from about 1.5 mg/mL to about 200 mg/mL, and the pyroglutamine content ranges from about 1% to about 200% relative to the theanine content;
  • FIG. 1 A graph showing the residual ratio of theanine after the preservation test with respect to theanine solutions of embodiments 3 to 7;
  • FIG. 2 A graph showing the residual ratio of theanine after the preservation test with respect to theanine solution of embodiment 8;
  • FIG. 3 A graph showing the residual ratio of theanine after the preservation test with respect to pH 2.8 theanine solution to which pyroglutamic acid ranging from 0% to 200% is added;
  • FIG. 4 A graph showing the residual ratio of theanine after the preservation test with respect to pH 7.5 theanine solution to which pyroglutamic acid ranging from 0% to 200% is added.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
US11/911,249 2005-04-28 2006-04-25 Hydrated Food Abandoned US20090011108A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005133107 2005-04-28
JP2005-133107 2005-04-28
PCT/JP2006/308595 WO2006118090A1 (ja) 2005-04-28 2006-04-25 含水食品

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/308595 A-371-Of-International WO2006118090A1 (ja) 2005-04-28 2006-04-25 含水食品

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/506,922 Continuation US20150080469A1 (en) 2005-04-28 2014-10-06 Hydrated food

Publications (1)

Publication Number Publication Date
US20090011108A1 true US20090011108A1 (en) 2009-01-08

Family

ID=37307890

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/911,249 Abandoned US20090011108A1 (en) 2005-04-28 2006-04-25 Hydrated Food
US14/506,922 Abandoned US20150080469A1 (en) 2005-04-28 2014-10-06 Hydrated food
US15/956,800 Active 2026-10-29 US10905764B2 (en) 2005-04-28 2018-04-19 Hydrated food

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/506,922 Abandoned US20150080469A1 (en) 2005-04-28 2014-10-06 Hydrated food
US15/956,800 Active 2026-10-29 US10905764B2 (en) 2005-04-28 2018-04-19 Hydrated food

Country Status (5)

Country Link
US (3) US20090011108A1 (es)
EP (1) EP1878350B1 (es)
JP (1) JP4990132B2 (es)
ES (1) ES2426580T3 (es)
WO (1) WO2006118090A1 (es)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8293299B2 (en) 2009-09-11 2012-10-23 Kraft Foods Global Brands Llc Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids
US20120301590A1 (en) * 2011-05-23 2012-11-29 George Castillo Hydrating gel composition with electrolytes and structure agent
US8592142B2 (en) * 2008-04-16 2013-11-26 Momenta Pharmaceuticals, Inc. Analysis of amino acid copolymer compositions
US11013248B2 (en) 2012-05-25 2021-05-25 Kraft Foods Group Brands Llc Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
US11925189B2 (en) 2021-02-26 2024-03-12 Taiyo Kagaku Co., Ltd. Gummy composition and method for producing the same

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
JP5721352B2 (ja) * 2010-07-05 2015-05-20 サントリー食品インターナショナル株式会社 ビタミン類含有飲料
JP5789089B2 (ja) * 2010-07-05 2015-10-07 サントリー食品インターナショナル株式会社 集中力向上剤
JP6050862B2 (ja) * 2015-06-10 2016-12-21 サントリー食品インターナショナル株式会社 集中力向上剤
US10375976B2 (en) * 2016-04-01 2019-08-13 Frito-Lay North America, Inc. Flavor-enhanced beverage product and method of enhancing the flavor thereof
JP6396970B2 (ja) * 2016-11-18 2018-09-26 サントリーホールディングス株式会社 集中力向上剤

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882706A (en) * 1994-07-15 1999-03-16 Kawashima; Toshio Food and drink and additive therefor
JP2001299266A (ja) * 2000-04-26 2001-10-30 Japan Tobacco Inc 調味料
US20020169202A1 (en) * 2001-01-29 2002-11-14 Ajinomoto Co. Inc Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
US6589566B2 (en) * 1998-02-23 2003-07-08 Tomoko Ueda Composition comprising theanine
US20040029955A1 (en) * 2002-05-15 2004-02-12 Takashi Kouge Composition for use in prevention or treatment of vascular-related diseases
US6719963B2 (en) * 1996-02-20 2004-04-13 Smithkline Beecham P.L.C. Liquid oral compositions comprising a calcium compound and an acidulant
US20040241294A1 (en) * 2003-05-31 2004-12-02 Barabolak Roman M. Edible films including aspartame and methods of making same
US20060211721A1 (en) * 2005-03-21 2006-09-21 Roberts Alan R Nutraceutical formulation of a cognitive enhancement system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028257B2 (ja) * 1981-04-09 1985-07-03 株式会社ロツテ 菓子用センタ−シロツプ
JPH0755154B2 (ja) 1991-09-14 1995-06-14 太陽化学株式会社 テアニンの製造方法
JPH05123166A (ja) 1991-10-31 1993-05-21 Food Design Gijutsu Kenkyu Kumiai 茶の培養細胞群の増殖法
JPH0630757A (ja) * 1992-07-09 1994-02-08 Nagasaki Pref Gov 枇杷果実酒の製造方法
JPH0847383A (ja) * 1994-08-08 1996-02-20 Ajinomoto Co Inc 冷凍食品類とその製造法
JP2792645B2 (ja) * 1996-03-29 1998-09-03 農林水産省食品総合研究所長 テアニンの製造方法
JP3152416B2 (ja) * 1996-12-12 2001-04-03 株式会社 伊藤園 茶の製造方法
JP3657118B2 (ja) 1998-07-09 2005-06-08 株式会社 伊藤園 テアニンの製造方法
JP2001081013A (ja) 1999-09-10 2001-03-27 Soken Kk 毛髪健全化剤
US20050129783A1 (en) * 2001-04-19 2005-06-16 Mccleary Edward L. Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
JP3536287B2 (ja) * 2001-01-29 2004-06-07 有限会社皆川商店 電子レンジ調理用包装材
EP1275308A1 (en) 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
JP4826696B2 (ja) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 血管新生阻害剤
JP4851046B2 (ja) * 2002-06-19 2012-01-11 味の素株式会社 細胞への塩基性アミノ酸取り込み促進剤および医薬組成物
JP4557581B2 (ja) * 2004-03-30 2010-10-06 宝酒造株式会社 新規みりん及びその製造方法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882706A (en) * 1994-07-15 1999-03-16 Kawashima; Toshio Food and drink and additive therefor
US6719963B2 (en) * 1996-02-20 2004-04-13 Smithkline Beecham P.L.C. Liquid oral compositions comprising a calcium compound and an acidulant
US6589566B2 (en) * 1998-02-23 2003-07-08 Tomoko Ueda Composition comprising theanine
JP2001299266A (ja) * 2000-04-26 2001-10-30 Japan Tobacco Inc 調味料
US20020169202A1 (en) * 2001-01-29 2002-11-14 Ajinomoto Co. Inc Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
US20040029955A1 (en) * 2002-05-15 2004-02-12 Takashi Kouge Composition for use in prevention or treatment of vascular-related diseases
US20040241294A1 (en) * 2003-05-31 2004-12-02 Barabolak Roman M. Edible films including aspartame and methods of making same
US20060211721A1 (en) * 2005-03-21 2006-09-21 Roberts Alan R Nutraceutical formulation of a cognitive enhancement system

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8592142B2 (en) * 2008-04-16 2013-11-26 Momenta Pharmaceuticals, Inc. Analysis of amino acid copolymer compositions
US9085796B2 (en) 2008-04-16 2015-07-21 Momenta Pharmaceuticals, Inc. Analysis of amino acid copolymer compositions
US9395374B2 (en) 2008-04-16 2016-07-19 Momenta Pharmaceuticals, Inc. Analysis of amino acid copolymer compositions
US9410964B2 (en) 2008-04-16 2016-08-09 Momenta Pharmaceuticals, Inc. Analysis of amino acid copolymer compositions
US10160992B2 (en) 2008-04-16 2018-12-25 Momenta Pharmaceuticals, Inc. Analysis of amino acid copolymer compositions
US8293299B2 (en) 2009-09-11 2012-10-23 Kraft Foods Global Brands Llc Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids
US8603557B2 (en) 2009-09-11 2013-12-10 Kraft Foods Group Brands Llc Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable concentrated liquids
US20120301590A1 (en) * 2011-05-23 2012-11-29 George Castillo Hydrating gel composition with electrolytes and structure agent
US11013248B2 (en) 2012-05-25 2021-05-25 Kraft Foods Group Brands Llc Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
US11925189B2 (en) 2021-02-26 2024-03-12 Taiyo Kagaku Co., Ltd. Gummy composition and method for producing the same

Also Published As

Publication number Publication date
JPWO2006118090A1 (ja) 2008-12-18
US20150080469A1 (en) 2015-03-19
EP1878350B1 (en) 2013-07-31
EP1878350A4 (en) 2009-12-23
ES2426580T3 (es) 2013-10-24
US20180236083A1 (en) 2018-08-23
JP4990132B2 (ja) 2012-08-01
US10905764B2 (en) 2021-02-02
EP1878350A1 (en) 2008-01-16
WO2006118090A1 (ja) 2006-11-09

Similar Documents

Publication Publication Date Title
US10905764B2 (en) Hydrated food
Leksrisompong et al. Bitter taste inhibiting agents for whey protein hydrolysate and whey protein hydrolysate beverages
TWI657746B (zh) 含有甜葉菊苷ｅ之可食用產品及使用其製備和強化可食用產品之甜味的方法
US20070213400A1 (en) Alcohol-metabolism enhancing composition and ingesta containing the same
US20030224062A1 (en) Food supplements containing 4-hydroxyisoleucine and creatine
JP2003235512A (ja) 呈味性が改善されたアミノ酸含有組成物
JP6939969B2 (ja) 経口液体組成物
CN100399948C (zh) 含氨基酸的饮料和减少氨基酸苦味的方法
US20070248648A1 (en) High protein, fatigue reducing powder
US20060105065A1 (en) Liquid seasoning
KR20170083508A (ko) 유리 아미노산 또는 이의 염을 함유하는 젤리
JP6552097B2 (ja) 飲食品の苦味改善剤、飲食品の苦味改善方法、及び飲食用組成物
CN108697679B (zh) 含氨基酸的组合物
Oprea et al. Pharmacological aspects and health impact of sports and energy drinks
JP4824152B2 (ja) 血流改善剤
JP2005232045A (ja) 抗ストレス及びリラックス用組成物
JP5355809B1 (ja) 飲料
JP2015063497A (ja) 経口用組成物
JP2002265359A (ja) カイニン酸型グルタミン酸受容体遮蔽剤、ａｍｐａ型グルタミン酸受容体遮蔽剤、脳保護剤及び脳保護機能を備えた飲食物
US20200297015A1 (en) Tryptophan derivatives as sweeteners
JP4319969B2 (ja) 液体調味料
WO2008026629A1 (fr) Composition alimentaire
JP2016149946A (ja) 飲料
JP6586337B2 (ja) 飲料
JP6234838B2 (ja) 飲料

Legal Events

Date Code Title Description
AS Assignment

Owner name: TAIYOKAGAKU CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KOGISO, SHIZUKA;OZEKI, MAKOTO;AOI, NOBUYUKI;REEL/FRAME:021506/0095;SIGNING DATES FROM 20080711 TO 20080811

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION